TALENs Targeting HBV: Designer Endonuclease Therapies for Viral Infections

Molecular Therapy- United States

doi 10.1038/mt.2013.208

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Antiviral Therapies for Respiratory Viral Infections in Lung Transplant Patients

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Potential Application of TALENs Against Murine Cytomegalovirus Latent Infections

Viruses
VirologyInfectious Diseases
2019English

Designer Organoids for Modeling Epigenetics, Signaling, and Therapies in Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

In Vivo Disruption of Latent HSV by Designer Endonuclease Therapy

JCI insight
Medicine
2016English

HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation

Journal of Clinical and Translational Hepatology
2018English

Myotonic Dystrophies: Targeting Therapies for Multisystem Disease

Neurotherapeutics
NeurologyPharmacology
2018English

Immunotherapy for Viral and Fungal Infections

Bone Marrow Transplantation
TransplantationHematology
2015English

Defensins in Viral Infections

Journal of Innate Immunity
AllergyImmunology
2009English

Editorial: Nephrotoxicity and Oral Anti-Viral Therapy for HBV-facts or Fiction?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy